All lobbying filings

ARENTFOX SCHIFF LLP

ARENTFOX SCHIFF LLP filed a Q1 report for TRANSPARENCY-RX CORP. on April 17, 2026, reporting $20,000 in lobbying income.

Lobbying for TRANSPARENCY-RX CORP. · Coalition of licensed transparent pharmacy benefit managers

All filings by ARENTFOX SCHIFF LLP · Everything TRANSPARENCY-RX CORP. has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 17, 2026

Income

$20,000

What the client paid this registrant for the period.

Client based in

Virginia

Official filing document

Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Pharmacy Benefit Manager reform Transparency in prescription drug markets Prescription drug prices H.R.7148 (Consolidated Appropriations Act, 2026), regarding Pharmacy Benefit Manager reform, transparency in prescription drug markets, and prescription drug prices

Bills named in this filing 1

H.R. 7148
Consolidated Appropriations Act, 2026

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.